INDEGENE Quarterly Results
| Consolidated | Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹942 Cr | ₹804 Cr | ₹761 Cr | ₹756 Cr | ₹720 Cr | ₹687 Cr | ₹677 Cr | ₹673 Cr |
| Expenses | ₹783 Cr | ₹664 Cr | ₹606 Cr | ₹608 Cr | ₹589 Cr | ₹561 Cr | ₹548 Cr | ₹534 Cr |
| Operating Income | ₹160 Cr | ₹141 Cr | ₹155 Cr | ₹148 Cr | ₹132 Cr | ₹126 Cr | ₹129 Cr | ₹139 Cr |
| Other Income | ₹19 Cr | ₹20 Cr | ₹22 Cr | ₹26 Cr | ₹38 Cr | ₹21 Cr | ₹23 Cr | ₹23 Cr |
| Interest | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹12 Cr | ₹12 Cr |
| Depreciation | ₹40 Cr | ₹23 Cr | ₹22 Cr | ₹21 Cr | ₹20 Cr | ₹19 Cr | ₹20 Cr | ₹19 Cr |
| Profit Before Tax | ₹135 Cr | ₹133 Cr | ₹152 Cr | ₹149 Cr | ₹146 Cr | ₹124 Cr | ₹120 Cr | ₹134 Cr |
| Profit After Tax | ₹103 Cr | ₹102 Cr | ₹116 Cr | ₹118 Cr | ₹110 Cr | ₹92 Cr | ₹88 Cr | ₹95 Cr |
| EPS | ₹4.29 | ₹4.25 | ₹4.86 | ₹4.91 | ₹4.59 | ₹3.84 | ₹3.66 | ₹4.27 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| INDEGENE | -0.5% | -7.8% | -16.7% |
| SUN PHARMACEUTICAL INDUSTRIES | 6.8% | -1.5% | -2.4% |
| DIVIS LABORATORIES | 0% | -4.8% | 8.3% |
| CIPLA | 0.1% | -12.8% | -9.3% |
| TORRENT PHARMACEUTICALS | 1.7% | 4.1% | 20.5% |
| DR REDDYS LABORATORIES | 1.8% | -0.7% | 3.4% |
| MANKIND PHARMA | -1.7% | -4.7% | -13.4% |
| ZYDUS LIFESCIENCES | 2.2% | -1.8% | -5.3% |
| LUPIN | 2% | 5.6% | 5.9% |
INDEGENE Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 17.15 % |
| Y-o-Y | 30.77 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Dec2025 | ₹942 Cr | 17.15 | |
| Sep2025 | ₹804 Cr | 5.70 | |
| Jun2025 | ₹761 Cr | 0.69 | |
| Mar2025 | ₹756 Cr | 4.89 | |
| Dec2024 | ₹720 Cr | 4.89 | |
| Sep2024 | ₹687 Cr | 1.52 | |
| Jun2024 | ₹677 Cr | 0.52 | |
| Mar2024 | ₹673 Cr | - | |
INDEGENE Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 13.44 % |
| Y-o-Y | 21.02 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Dec2025 | ₹160 Cr | 13.44 | |
| Sep2025 | ₹141 Cr | -9.47 | |
| Jun2025 | ₹155 Cr | 5.29 | |
| Mar2025 | ₹148 Cr | 11.91 | |
| Dec2024 | ₹132 Cr | 4.52 | |
| Sep2024 | ₹126 Cr | -2.17 | |
| Jun2024 | ₹129 Cr | -7.07 | |
| Mar2024 | ₹139 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -3.15 % |
| Y-o-Y | -7.49 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Dec2025 | 16.93% | -3.15 | |
| Sep2025 | 17.48% | -14.36 | |
| Jun2025 | 20.41% | 4.56 | |
| Mar2025 | 19.52% | 6.67 | |
| Dec2024 | 18.3% | -0.33 | |
| Sep2024 | 18.36% | -3.62 | |
| Jun2024 | 19.05% | -7.57 | |
| Mar2024 | 20.61% | - | |
INDEGENE Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 0.78 % |
| Y-o-Y | -6.20 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Dec2025 | ₹103 Cr | 0.78 | |
| Sep2025 | ₹102 Cr | -12.29 | |
| Jun2025 | ₹116 Cr | -1.02 | |
| Mar2025 | ₹118 Cr | 7.20 | |
| Dec2024 | ₹110 Cr | 19.63 | |
| Sep2024 | ₹92 Cr | 4.56 | |
| Jun2024 | ₹88 Cr | -7.49 | |
| Mar2024 | ₹95 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -14.02 % |
| Y-o-Y | -28.30 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Dec2025 | 10.92 % | -14.02 | |
| Sep2025 | 12.7 % | -16.99 | |
| Jun2025 | 15.3 % | -1.67 | |
| Mar2025 | 15.56 % | 2.17 | |
| Dec2024 | 15.23 % | 14.08 | |
| Sep2024 | 13.35 % | 3.01 | |
| Jun2024 | 12.96 % | -8.02 | |
| Mar2024 | 14.09 % | - | |
INDEGENE Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 0.94 % |
| Y-o-Y | -6.54 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Dec2025 | ₹4.29 | 0.94 | |
| Sep2025 | ₹4.25 | -12.55 | |
| Jun2025 | ₹4.86 | -1.02 | |
| Mar2025 | ₹4.91 | 6.97 | |
| Dec2024 | ₹4.59 | 19.53 | |
| Sep2024 | ₹3.84 | 4.92 | |
| Jun2024 | ₹3.66 | -14.29 | |
| Mar2024 | ₹4.27 | - | |
You may also like the below Video Courses
Check out Intrinsic Value of Industry Peers of INDEGENE
